©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 110628
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.110628
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.110628
Table 3 Predictors of left ventricular hypertrophy, n (%)/mean ± SD
| Variables | Univariate analysis | Multivariate analysis | |||
| LVH | No LVH | P value | OR (95%CI) | P value | |
| Age | 0.28 | ||||
| 18-50 years | 49 (33) | 100 (67) | |||
| > 50 years | 43 (39) | 66 (61) | |||
| Gender | 0.004 | 2.51 (1.17-5.41) | 0.02 | ||
| Male | 76 (42) | 91 (58) | |||
| Female | 25 (25) | 75 (75) | |||
| Obesity | 29 (33) | 60 (67) | 0.49 | ||
| BMI ranges | 0.78 | ||||
| < 25 | 46 (38) | 76 (62) | |||
| 25-30 | 25 (33) | 51 (67) | |||
| > 30 | 21 (35) | 39 (65) | |||
| PH | 34 (52) | 58 (30) | 0.002 | 2.07 (1.11-3.86) | 0.02 |
| Mitral regurgitation (grade 2-4) | 49 (39) | 33 (35) | 0.56 | ||
| Tricuspid regurgitation | 33 (37) | 59 (36) | 0.89 | ||
| Aortic regurgitation | 18 (40) | 74 (35) | 0.61 | ||
| LVSD | 17 (55) | 14 (45) | 0.016 | 2.11 (0.89-5.02) | 0.09 |
| DD | 38 (54) | 33 (46) | < 0.001 | 2.47 (1.29-4.73) | 0.006 |
| MR (grade 2-3) | 49 (39) | 77 (61) | 0.58 | ||
| TR | 59 (36) | 107 (64) | 0.89 | ||
| AR | 18 (40) | 27 (60) | 0.61 | ||
| Hypertension | 91 (36) | 160 (64) | 0.43 | ||
| Pericardial effusion | 18 (44) | 33 (56) | 0.24 | ||
| Dyslipidemia | 46 (48) | 50 (52) | 0.002 | 1.94 (1.07-3.53) | 0.03 |
| Smoking | 49 (40) | 72 (60) | 0.13 | 0.46 (0.36-1.58) | 0.46 |
| Diabetes | 15 (44) | 19 (56) | 0.27 | ||
| Impaired fasting glucose | 55 (42) | 75 (58) | 0.03 | 1.38 (0.76-2.50) | 0.30 |
| Hyperuricemia | 27 (35) | 50 (65) | 0.90 | ||
| Duration of dialysis in months | 22.23 ± 19.71 | 23.00 ± 23.15 | 0.79 | ||
| Total-cholesterol (mmol/L) | 4.49 ± 1.27 | 4.36 ± 1.09 | 0.40 | ||
| LDL cholesterol (mmol/L) | 2.93 ± 3.16 | 2.55 ± 0.90 | 0.26 | ||
| HDL cholesterol (mmol/L) | 1.25 ± 0.50 | 1.23 ± 0.49 | 0.74 | ||
| Triglyceride (mmol/L) | 1.72 ± 1.17 | 1.54 ± 1.12 | 0.23 | ||
| Phosphate (mmol/L) | 1.54 ± 0.56 | 1.53 ± 0.57 | 0.88 | ||
| PTH (pmol/L) | 22.68 ± 25.95 | 29.52 ± 27.12 | 0.17 | 1.00 (0.98-1.02) | 0.79 |
| Family history of coronary artery disease | 4 (20) | 16 (80) | 0.13 | 0.37 (0.11-1.30) | 0.12 |
| Pre-emptive transplant | 6 (43) | 8 (57) | 0.82 | ||
| Hemodialysis | 74 (36) | 133 (64) | |||
| Peritoneal dialysis | 12 (33) | 24 (67) | |||
- Citation: Sadagah NM, Khalil MAM, Mahmood HHK, Alghamdi IA, Buridi GA, Al-Qurashi SH. Silent cardiac burden: Echocardiographic abnormalities and their predictors in kidney transplant candidates and their impact on graft function. World J Transplant 2026; 16(1): 110628
- URL: https://www.wjgnet.com/2220-3230/full/v16/i1/110628.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i1.110628